174 related articles for article (PubMed ID: 34216315)
1. Polycystic ovary syndrome: epidemiologic assessment of prevalence of systemic rheumatic and autoimmune diseases.
Sharmeen S; Nomani H; Taub E; Carlson H; Yao Q
Clin Rheumatol; 2021 Dec; 40(12):4837-4843. PubMed ID: 34216315
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovary syndrome with hyperandrogenism as a risk factor for non-obese non-alcoholic fatty liver disease.
Kim JJ; Kim D; Yim JY; Kang JH; Han KH; Kim SM; Hwang KR; Ku SY; Suh CS; Kim SH; Choi YM
Aliment Pharmacol Ther; 2017 Jun; 45(11):1403-1412. PubMed ID: 28370150
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome.
Garelli S; Masiero S; Plebani M; Chen S; Furmaniak J; Armanini D; Betterle C
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):248-51. PubMed ID: 23548659
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
Becerra-Fernández A; Pérez-López G; Román MM; Martín-Lazaro JF; Lucio Pérez MJ; Asenjo Araque N; Rodríguez-Molina JM; Berrocal Sertucha MC; Aguilar Vilas MV
Endocrinol Nutr; 2014; 61(7):351-8. PubMed ID: 24680383
[TBL] [Abstract][Full Text] [Related]
6. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study.
West S; Lashen H; Bloigu A; Franks S; Puukka K; Ruokonen A; Järvelin MR; Tapanainen JS; Morin-Papunen L
Hum Reprod; 2014 Oct; 29(10):2339-51. PubMed ID: 25085801
[TBL] [Abstract][Full Text] [Related]
7. Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.
Sarahian N; Sarvazad H; Sajadi E; Rahnejat N; Eskandari Roozbahani N
Reprod Health; 2021 Jul; 18(1):156. PubMed ID: 34311759
[TBL] [Abstract][Full Text] [Related]
8. Impact of Autoimmune Thyroiditis on Reproductive and Metabolic Parameters in Patients with Polycystic Ovary Syndrome.
Ulrich J; Goerges J; Keck C; Müller-Wieland D; Diederich S; Janssen OE
Exp Clin Endocrinol Diabetes; 2018 Apr; 126(4):198-204. PubMed ID: 29506313
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of polycystic ovary syndrome and hyperandrogenemia in female-to-male transsexuals.
Mueller A; Gooren LJ; Naton-Schötz S; Cupisti S; Beckmann MW; Dittrich R
J Clin Endocrinol Metab; 2008 Apr; 93(4):1408-11. PubMed ID: 18211977
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran.
Tehrani FR; Rashidi H; Khomami MB; Tohidi M; Azizi F
Reprod Biol Endocrinol; 2014 Sep; 12():89. PubMed ID: 25224635
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovary syndrome and autoimmunity.
Petríková J; Lazúrová I; Yehuda S
Eur J Intern Med; 2010 Oct; 21(5):369-71. PubMed ID: 20816585
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Polycystic Ovarian Syndrome in Young and Adolescent Transmasculine Patients Presenting for Gender-Affirming Care.
Rangi SK; Rehmer J; Ferrando CA
J Pediatr Adolesc Gynecol; 2024 Feb; 37(1):51-55. PubMed ID: 37696388
[TBL] [Abstract][Full Text] [Related]
13. Polycystic Ovary Syndrome.
Azziz R
Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
[TBL] [Abstract][Full Text] [Related]
14. A genetic risk score is associated with polycystic ovary syndrome-related traits.
Lee H; Oh JY; Sung YA; Chung HW
Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
[TBL] [Abstract][Full Text] [Related]
16. Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome.
Zhao X; Zhong J; Mo Y; Chen X; Chen Y; Yang D
Int J Gynaecol Obstet; 2010 Feb; 108(2):148-51. PubMed ID: 19932893
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
Cooney LG; Lee I; Sammel MD; Dokras A
Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
[TBL] [Abstract][Full Text] [Related]
18. DIAGNOSTIC VALUE OF ANTI-MÜLLERIAN HORMONE AS A BIOMARKER FOR POLYCYSTIC OVARY SYNDROME: A META-ANALYSIS UPDATE.
Zhao Y; Zhao Y; Wang C; Liang Z; Liu X
Endocr Pract; 2019 Oct; 25(10):1056-1066. PubMed ID: 31414908
[No Abstract] [Full Text] [Related]
19. Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population.
Salva-Pastor N; López-Sánchez GN; Chávez-Tapia NC; Audifred-Salomón JR; Niebla-Cárdenas D; Topete-Estrada R; Pereznuñez-Zamora H; Vidaltamayo-Ramírez R; Báez-Arellano ME; Uribe M; Nuño-Lámbarri N
Ann Hepatol; 2020; 19(3):251-257. PubMed ID: 32111488
[TBL] [Abstract][Full Text] [Related]
20. Impact of the newly recommended antral follicle count cutoff for polycystic ovary in adult women with polycystic ovary syndrome.
Kim JJ; Hwang KR; Chae SJ; Yoon SH; Choi YM
Hum Reprod; 2020 Mar; 35(3):652-659. PubMed ID: 32211797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]